Pharma: Boehringer Remains Independent - No IPO Planned

Zeit Online

Lean Left

Factuality

Ownership

Here you will find information on the topic "Pharmaceuticals". Read now "Boehringer remains independent – no IPO planned".

volksfreund.de

saarbruecker-zeitung.de

Center

View article

Reposted by

saarbruecker-zeitung.de

Center

Factuality

Ownership

Despite billions of investments in research, Boehringer Ingelheim remains independent. Head of the company Deshpande wants to remain independent of external capital.

lokalo.de

Factuality

Ownership

INGELHEIM – For the family-owned pharmaceutical giant Boehringer Ingelheim, an IPO is not an issue. "Our financial independence is our top priority," Group CEO Shashank Deshpande told "Manager Magazin". He then told the German press agency in Mainz on request: "Boehringer Ingelheim does not aim for stock market listing." One wants to continue to grow, is and [...]

manager magazin

Factuality

Ownership

The pharmaceutical company Boehringer Ingelheim is one of the world leaders. CEO Shashank Deshpande explains why the family company still does not want to be listed on the stock market and what the placement of the family on the richest list means for its work.